Holen Sie sich die Stockscreener-App
1.38
0.72%
-0.01
Handel nachbörslich:
1.38
Schlusskurs vom Vortag:
$1.39
Offen:
$1.4032
24-Stunden-Volumen:
41,571
Relative Volume:
0.19
Marktkapitalisierung:
$7.56M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.91M
KGV:
-0.4233
EPS:
-3.26
Netto-Cashflow:
$-6.14M
1W Leistung:
-6.12%
1M Leistung:
+8.66%
6M Leistung:
-4.17%
1J Leistung:
-79.88%
1-Tages-Spanne:
$1.37
$1.4477
1-Wochen-Bereich:
$1.35
$1.47
52-Wochen-Spanne:
$1.15
$6.8653
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie GLMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.38 | 7.62M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
Galmed Pharmaceuticals Ltd. stock prediction for this weekFed Meeting & Technical Pattern Alert System - newser.com
Combining machine learning predictions for Galmed Pharmaceuticals Ltd.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
What the charts say about Galmed Pharmaceuticals Ltd. todayTrade Entry Summary & Low Volatility Stock Suggestions - newser.com
Is Galmed Pharmaceuticals Ltd. stock a top momentum playJuly 2025 Pullbacks & Long-Term Growth Plans - newser.com
How Galmed Pharmaceuticals Ltd. stock reacts to Fed rate cutsTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Why Galmed Pharmaceuticals Ltd. stock remains on buy lists2025 Price Momentum & AI Enhanced Trading Alerts - newser.com
What drives Galmed Pharmaceuticals Ltd GPH stock priceRelative Strength Index (RSI) & High Yield Trading Growth - earlytimes.in
Will Galmed Pharmaceuticals Ltd. (GPH) stock outperform benchmarksMarket Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
News impact scoring models applied to Galmed Pharmaceuticals Ltd.Weekly Trend Recap & High Conviction Buy Zone Picks - newser.com
Can Galmed Pharmaceuticals Ltd. (GPH) stock withstand sector downturnsJuly 2025 Highlights & Real-Time Volume Analysis - newser.com
Can volume confirm reversal in Galmed Pharmaceuticals Ltd.Portfolio Return Report & Low Volatility Stock Suggestions - newser.com
Galmed Pharmaceuticals Ltd Stock Analysis and ForecastTake Profit Strategies & Superior Capital Investment - Early Times
What analysts say about Galmed Pharmaceuticals Ltd stockCovered Call Writing & Predict Price Movements With AI Precision - earlytimes.in
Is Galmed Pharmaceuticals Ltd a good long term investmentBullish Engulfing Patterns & High Yield Portfolio Picks - Early Times
Can Galmed Pharmaceuticals Ltd. recover in the next quarterEarnings Summary Report & Verified High Yield Trade Plans - newser.com
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):